Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

ergometrine/feber

Länken sparas på Urklipp
ArtiklarKliniska testerPatent
7 resultat
OBJECTIVE To compare the efficacy and side effects of 0.2 mg methyl-ergometrine IM, 400 microg misoprostol sublingual and 125 microg 15 methyl PGF2alpha IM in active management of third stage of labor. METHODS Two hundred low risk pregnant women with induced or spontaneous labor were randomized to
OBJECTIVE The purpose of the study was to compare the efficacy of misoprostol 400 μg per rectally, injection oxytocin 10 IU intramuscular, injection methylergometrine 0.2 mg intravenously and injection (0.5 mg ergometrine + 5 IU oxytocin) intramuscular on reducing blood loss in third stage of labor,

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide. Prophylactic uterotonic drugs can prevent PPH, and are routinely recommended. There are several uterotonic drugs for preventing PPH but it is still debatable which drug is best. To identify the most effective
OBJECTIVE To compare misoprostol with standard oxytocic regimens in the prevention of postpartum haemorrhage. METHODS Randomised controlled trial. METHODS Obstetric unit in a large teaching hospital. METHODS One thousand women randomised to 500 microg misoprostol given orally or to standard oxytocic

Intraumbilical veinous injection oxytocin in the active management of third stage of labour.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To determine the role of intraumbilical vein oxytocin reducing blood loss during and after one hour of delivery of placenta and its efficacy in reducing the frequency of retained placenta. METHODS Randomized controlled trial. METHODS Combined Military Hospital, Multan, from June 2002 to

Treatment for primary postpartum haemorrhage.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Primary postpartum haemorrhage (PPH) is one of the top five causes of maternal mortality in both developed and developing countries. OBJECTIVE To assess the effectiveness and safety of pharmacological, surgical and radiological interventions used for the treatment of primary

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely recommended. The current World Health Organization (WHO) recommendation for preventing PPH is 10 IU (international units) of
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge